Edesa biotech, inc. (SBOT)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Aug'14Aug'13
Assets:
Current assets:
Cash and cash equivalents

6,989

3,827

5,030

6,363

7,684

3,367

4,225

5,820

3,293

4,369

4,570

3,647

4,601

5,885

7,416

4,787

5,961

3,887

3,955

10,161

11,145

12,763

8,768

8,423

7,859

Accounts and other receivable

84

109

217

345

40

7

41

10

62

10

1

11

65

12

85

9

10

35

157

112

16

35

44

56

177

Short-term investments

-

499

-

-

0

-

6,078

5,463

499

998

1,994

3,997

3,994

3,993

3,988

1,999

1,999

5,016

5,015

0

0

0

5,450

5,462

0

Deferred share issuance costs

-

116

-

-

-

-

-

-

-

-

-

-

-

-

-

238

-

-

-

-

-

-

-

-

-

Inventory

-

-

-

77

243

-

224

237

205

118

68

140

310

329

249

568

543

527

557

194

135

134

34

0

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62

Prepaid expenses and deposits

352

274

397

337

170

16

86

101

209

159

123

321

376

368

358

123

200

224

181

256

145

86

125

128

34

Total current assets

7,426

4,827

5,644

7,123

8,138

3,390

10,655

11,633

4,270

5,657

6,758

8,119

9,348

10,589

12,099

7,726

8,715

9,692

9,866

10,725

11,442

13,020

14,423

14,070

8,134

Equity investment in joint venture

-

-

-

-

0

-

46

66

66

66

66

66

66

66

66

66

-

-

0

-

-

-

-

-

-

Property, plant and equipment, net

25

48

73

88

996

7

1,062

1,085

976

854

879

820

792

795

756

691

697

646

503

471

368

389

388

387

246

Operating lease right-of-use assets

181

213

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licensing rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

116

Deposits

-

-

-

-

15

-

15

15

15

15

15

15

15

15

15

15

15

15

15

15

15

15

15

15

15

Total noncurrent assets

-

-

-

-

1,012

-

1,123

1,167

1,058

936

961

902

874

877

838

773

713

661

519

487

384

405

404

403

378

Total assets

7,632

5,089

5,717

7,227

9,151

3,398

11,779

12,801

5,329

6,593

7,720

9,022

10,222

11,467

12,937

8,500

9,428

10,354

10,385

11,213

11,826

13,425

14,827

14,473

8,513

Liabilities and shareholders' equity:
Current liabilities:
Accounts payable and accrued liabilities

516

637

461

1,015

801

183

493

414

589

574

320

425

433

602

623

665

442

723

656

371

413

550

585

526

419

Short-term operating lease liabilities

62

66

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

80

-

0

-

-

-

-

-

-

-

-

173

173

0

173

173

0

86

86

15

0

Warrant liability, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,550

1,235

2,489

3,318

0

879

3,454

Total current liabilities

578

704

461

1,015

881

183

493

414

589

574

320

425

433

602

623

839

616

723

2,380

1,780

2,903

3,955

672

1,420

3,874

Non-current liabilities:
Long-term operating lease liabilities

122

151

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

233

3,690

5,352

-

Warrant liability, including current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,835

Total liabilities

701

855

461

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,780

2,903

4,188

4,362

6,773

10,709

Commitments (Note 6)

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

Shareholders' equity:
Authorized unlimited common and preferred shares without par value issued and outstanding: 8,859,159 common shares (2019 - 7,504,468)

14,732

12,005

12,005

12,005

56,652

1,111

56,652

56,652

48,351

48,351

48,351

48,351

47,280

47,280

47,280

41,336

41,336

41,336

38,114

37,940

37,940

37,940

37,883

36,240

13,180

Common shares subscribed

-

45

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,155

Preferred shares

-

-

-

0

-

6,064

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

1,880

336

327

317

-

230

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive loss

-363

-323

-342

-329

-

-429

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated share-based compensation

-

-

-

-

5,109

-

5,064

5,035

4,533

4,460

4,439

4,416

5,459

5,431

5,394

5,345

5,302

5,259

5,226

5,289

5,244

5,131

5,073

5,079

4,648

Accumulated deficit

-9,318

-7,828

-6,734

-5,780

-53,493

-3,761

-50,430

-49,301

-48,145

-46,792

-45,392

-44,171

-42,950

-41,847

-40,361

-39,020

-37,826

-36,965

-35,335

-33,797

-34,261

-33,835

-32,492

-33,620

-25,180

Total shareholders' equity

6,930

4,233

5,256

6,212

8,269

3,214

11,286

12,386

4,739

6,019

7,399

8,596

9,789

10,864

12,314

7,661

8,812

9,630

8,005

9,432

8,922

9,236

10,464

7,700

-2,195

Total liabilities and shareholders' equity

7,632

5,089

5,717

7,227

9,151

3,398

11,779

12,801

5,329

6,593

7,720

9,022

10,222

11,467

12,937

8,500

9,428

10,354

10,385

11,213

11,826

13,425

14,827

14,473

8,513